13
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans

, &
Pages 354-361 | Published online: 09 Jul 2009

References

  • Brophy JJ, Davies NW, Southwell IA, Stiff IA, Williams LR. Gas chromatographic quality control for oil of Melaleuca ter-pinen-4-ol type (Australian tea tree). J Agric Food Chem 1989; 37: 1330–1335.
  • Carson CF, Riley TV. Antimicrobial activity of the essential oil of Melaleuca alternifolia. Lett Appl Microbiol 1993; 16: 49–55.
  • Osborne F, Chandler F. Australian tea tree oil. Canadian Pharm J 1998; 131: 42–46.
  • Nenoff P, Haustein U-F, Brandt W. Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol 1996; 9: 388–394.
  • Concha JM, Moore LS, Holloway WJ. Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms. J Am Podiatr Med Assoc 1998; 88: 489–492.
  • Hammer KA, Carson CF, Riley TV. In-vitro activity of essen-tial oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. J Antimicrob Chemother 1998; 42: 591–595.
  • Elsom GKF, Hide D. Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin. J Antimi-crob Chemother 1999; 43: 427–428.
  • Hammer KA, Carson CF, Riley TV. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro. J Appl Microbiol 1999; 86: 446–452.
  • Tong MM, Altman PM, Bametson RStC. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 1992; 33: 145–149.
  • Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 1994; 38: 601–605.
  • Jandourek A, Vaishampayan JK, Vazquez JA. Efficacy of melaleuca oral solution for the treatment of fluconazole refrac-tory oral candidiasis in AIDS patients. AIDS 1998; 12: 1033–1037. 0 2000 ISHAM, Medical Mycology, 38, 355-362
  • Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA. Treat-ment of toenail onychomycosis with 2% butenafme and 5% Melaleuca alternifolia (tea tree) oil in cream. Trop Med Int Health 1999; 4: 284–287.
  • Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462–478.
  • Odds FC. Candida and Candidosis, 2nd edn. London: Baillière Tindall, 1988.
  • Ellepola AN, Samaranayake LP. The effect of limited exposure to antifungal agents on the germ tube formation of oral Can-dida albicans. J Oral Pathol Med 1998; 27: 213–219.
  • Sobel JD, Muller G, Buckley HR. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect Im-man 1984; 44: 576–580.
  • Cutler JE Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187–218.
  • Kobayashi SD, Cutler JE. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol 1998; 6: 92–94.
  • Gow NA. Germ tube growth of Candida albicans. Curr Top Med Mycol 1997; 8: 43–55.
  • International Organisation for Standardisation. ISO 4730 Oil of Melaleuca, Terpinen-4-ol Type (Tea tree oil). Geneva: Interna-tional Organisation for Standardisation, 1996.
  • National Committee for Clinical Laboratory Standards. Refer-ence Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. Wayne, PA: NCCLS, 1997.
  • Finegold SM, Baron El (eds). Bailey and Scott's Diagnostic Microbiology. St Louis: The C. V. Mosby Group, 1986.
  • Warnock DW, Johnson EM, Burke J, Pracharktam R. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans. J Antimicrob Chemother 1989; 23: 837–847.
  • Chaffin WL. Effect of tunicamycin on germ tube and yeast bud formation in Candida albicans. J Gen Microbiol 1985; 131: 1853–1861.
  • Lynch ME, Kukuruga M, Nakeff A, Fidel PL, Sobel JD. Flow cytometric analysis of germ tube formation in Candida albicans. J Med Vet Mycol 1993; 31: 367–376.
  • Hubbard MJ, Sullivan PA, Shepherd MG. Morphological stud-ies of N-acetylglucosamine induced germ tube formation by Candida albicans. Can J Microbiol 1985; 31: 696–701.
  • Odds FC, Cockayne A, Hayward J, Abbott AB. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J Gen Microbiol 1985; 131: 2581–2589.
  • Johnson EM, Richardson MD, Warnock DW. Effect of imida-zole antifungals on the development of germ tubes by strains of Candida albicans. J Antimicrob Chemother 1983; 12: 303–316.
  • Ha KC, White TC. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 1999; 43: 763–768.
  • Taniguchi M, Yano Y, Tada E, et al. Mode of action of polygodial, an antifungal sesquiterpene dialdehyde. Agric Biol Chem 1988; 52: 1409–1414.
  • Barel S, Yashphe J. Effect of the essential oil from Achillea fragrantissima on Escherichia coli cells. Curr Microbiol 1989; 19: 337–341.
  • Cox S, Gustafson JE, Mann CM, et al. Tea tree oil causes K leakage and inhibits respiration in Escherichia coli. Lett Appl Microbiol 1998; 26: 355–358.
  • Sikkema J, de Bont JAM, Poolman B. Mechanisms of mem-brane toxicity of hydrocarbons. Microbiol Rev 1995; 59: 201–222.
  • Bard M, Albrecht MR, Gupta N, Guynn CJ, Stillwell W. Geraniol interferes with membrane functions in strains of Can-dida and Saccharomyces. Lipids 1988; 23: 534–538.
  • Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet Mycol 1997; 35: 79–86.
  • Uribe S, Ramirez J, Perla A. Effects of 13-pinene on yeast membrane functions. J Bacteriol 1985; 161: 1195–1200.
  • Inouye S, Watanabe M, Nishiyama Y, Takeo K, Akao M, Yamaguchi H. Antisporulating and respiratory-inhibiting ef-fects of essential oils on filamentous fungi. Mycoses 1998; 41: 403–410.
  • Boonchird C, Flegel TW. In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neofor-mans. Can J Microbiol 1982; 28: 1235–1241.
  • Peiia EF. Melaleuca alternifolia oil, its use for trichomonal vaginitis and other vaginal infections. Obstet Gynecol 1962; 19: 793–795.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.